LJUIF (SSY Group) GF Value Rank: 9 (As of Aug. 08, 2026) — 13% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LJUIF SSY Group Ltd LJUIF
87 GF Score
Price $0.40
GF Value $0.51
! 8 Warning Signs
View Full Analysis

What is SSY Group GF Value Rank?

SSY Group LJUIF 87 GF Value Rank is 9 as of Aug. 08, 2026, which is 13% above its 10-year median of 8.00. GuruFocus rates LJUIF with a GF Score™ of 87/100 and a GF Value™ of $0.51. The stock has 8 warning signs investors should review.

SSY Group has the GF Value Rank of 9.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

LJUIF vs ZTS: GF Value Rank Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SSY Group GF Value Rank vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SSY Group's GF Value Rank distribution charts can be found below:

* The bar in red indicates where SSY Group's GF Value Rank falls into.


LJUIF
87GF Score
SSY Group Ltd LJUIF
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 9 mean?
SSY Group (LJUIF) has a GF Value Rank of 9 as of Aug. 08, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on SSY Group and its competitors. This is 13% above median its historical median of 8.00. Over the past decade, SSY Group's GF Value Rank has ranged from 1.00 to 10.00.
Is SSY Group's GF Value Rank too high?
SSY Group's current GF Value Rank of 9 is 13% above median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, SSY Group has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does SSY Group's GF Value Rank compare to ZTS?
SSY Group's GF Value Rank of 9 can be compared against companies in the Drug Manufacturers industry. Historically, SSY Group's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Drug Manufacturers company?
A good GF Value Rank depends on the Drug Manufacturers industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on SSY Group and its competitors. SSY Group's current GF Value Rank is 9, which is 13% above median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SSY Group stock overvalued right now?
SSY Group (LJUIF) has a current GF Value Rank of 9. The stock's GF Value™ is $0.51, compared to a current price of $0.40 — trading 21.1% below its estimated fair value. The current GF Value Rank is 9, which is 13% above median its 10-year median of 8.00. SSY Group's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For SSY Group (LJUIF), the current GF Value Rank is 9 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SSY Group (LJUIF) Overvalued in 2026?

Based on GuruFocus' analysis, SSY Group stock appears to be undervalued. The current stock price of $0.40 is trading 21.1% below its estimated GF Value™ of $0.51.

Key valuation signals for LJUIF:

  • GF Value Rank: 9 (13% above median its 10-year median of 8.00)
  • GF Value™: $0.51 vs. price of $0.40 (21.1% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the LJUIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SSY Group Business Description

Other Exchanges 02005:Hong Kong
Address Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG
SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products. The company derives maximum revenue from PRC.
87GF Score

Get the complete analysis for LJUIF

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.51
GF Value